• Exchange: Shanghai
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Tasly Pharmaceutical Group Co Ltd

+ Add to Watchlist

600535:CH

46.100 CNY 1.850 4.18%

As of 00:11:12 ET on 01/26/2015.

Snapshot for Tasly Pharmaceutical Group Co Ltd (600535)

Open: 44.430 Day's Range: 44.390 - 46.600 Volume: 10,306,025
Previous Close: 44.250 52wk Range: 35.350 - 47.600 1-Yr Rtn: +2.08%

Stock Chart for 600535

No chart data available.
  • 600535:CH 46.100
  • 1D
  • 1M
  • 1Y
44.250
Interactive 600535 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 600535

Current P/E Ratio (ttm) 35.7444
Estimated P/E(12/2014) 33.2805
Relative P/E vs. SHASHR 2.2306
Earnings Per Share (CNY) (ttm) 1.2914
Est. EPS (CNY) (12/2014) 1.3870
Est. PEG Ratio -
Market Cap (M CNY) 47,676.02
Shares Outstanding (M) 1,032.84
30 Day Average Volume 11,108,820
Price/Book (mrq) 10.3470
Price/Sale (ttm) 3.9315
Dividend Indicated Gross Yield 0.76%
Cash Dividend (CNY) 0.3500
Dividend Ex-Date 06/19/2014
5 Year Dividend Growth 11.84%
Next Earnings Announcement 03/30/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 600535

  • Revenue
  • Net Income (M/CNY)
  • Profit Margin (%)

Company Profile & Key Executives for 600535

Tasly Pharmaceutical Group Co researches, produces, and sells Chinese medicines which are mainly derived from the root of red-rooted salvia. The Company's products focus on the treatment of cardiovascular and brain blood vessel diseases.

Yan XijunChairmanZhu YonghongVice Chairman
Kaijing YanPresidentJinyong CaiVice President
More Company Profile & Key Executives for 600535

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil